{"id":"NCT00333840","sponsor":"Novartis Pharmaceuticals","briefTitle":"Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia","officialTitle":"A Phase III Study of STI571 Versus Interferon-α (IFN-α) Combined With Cytarabine (Ara-C) in Patients With Newly Diagnosed Previously Untreated Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-06","primaryCompletion":"2012-03","completion":"2012-03","firstPosted":"2006-06-06","resultsPosted":"2013-10-14","lastUpdate":"2013-10-14"},"enrollment":1106,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Myelogenous Leukemia"],"interventions":[{"type":"DRUG","name":"imatinib mesilate","otherNames":["Glivec®","Gleevec®","STI571"]},{"type":"DRUG","name":"interferon-alpha (INF-a)","otherNames":["Roferon®-A","Intron®-A"]},{"type":"DRUG","name":"cytarabine (ARA-C)","otherNames":[]}],"arms":[{"label":"imatinib (STI571)","type":"EXPERIMENTAL"},{"label":"IFN-a+Ara-C","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate and compare the side effects and anti-leukemic benefits of imatinib with those of interferon and Ara-C for patients who have chronic myeloid leukemia (CML) in the chronic phase. Patients in this study will be randomized (1:1) to receive either interferon plus Ara-C or imatinib as initial treatment.","primaryOutcome":{"measure":"Kaplan-Meier Estimates of Overall Survival (All Randomized Participants)","timeFrame":"12,24,36,48,60,72,84,96,108,120,132 and 144 months","effectByArm":[{"arm":"Imatinib (STI571)","deltaMin":98.9,"sd":null},{"arm":"IFN-a + Ara-C","deltaMin":97.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":163,"countries":["United States","Australia","Austria","Belgium","Canada","Denmark","France","Germany","Italy","Netherlands","New Zealand","Norway","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["28273028","23620574","18256322"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":226,"n":551},"commonTop":["Nausea","Fatigue","Diarrhoea","Headache","Muscle spasms"]}}